Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 3/20 | 0.50 |
| ▸ | CYP2D6 | P10635 | 2/20 | 0.50 |
| ▸ | CA9 | Q16790 | 2/20 | 0.50 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | TP53 | P04637 | 1/20 | 0.41 |
| ▸ | TSHR | P16473 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 4/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 3/20 | 0.37 |
| ▸ | CASP1 | P29466 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | SLC6A3 | Q01959 | 4/20 | 0.31 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.31 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11101054 | 0.98 | CYP2D6 (0.48) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL11127614 | 0.98 | CYP2D6 (0.48) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL11106648 | 0.98 | CYP2D6 (0.48) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL514933 | 0.95 | CYP2D6 (0.50) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL14678439 | 0.90 | TSHR (0.45) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL18268908 | 0.89 | CYP2D6 (0.50) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL179200 | 0.89 | CYP2D6 (0.50) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL3821804 | 0.87 | CYP2D6 (0.49) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL8846065 | 0.87 | CYP2D6 (0.49) | CA1CYP2D6CA9ALDH1A1LMNA | |
| SCHEMBL15577086 | 0.87 | CYP2D6 (0.49) | CA1CYP2D6CA9ALDH1A1LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 94 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2023052127-A1 | PVC MIXTURE | LEONI KABEL GMBH (DE) | 2023-04-06 | — | — | WO | claimed |
| EP-4722295-A1 | RESIN COMPOSITION | Kuraray Co., Ltd. (JP) | 2026-04-08 | — | — | EP | disclosed |
| WO-2024248115-A1 | RESIN COMPOSITION | 株式会社クラレ | 2024-12-05 | — | — | WO | disclosed |
| US-20240335571-A1 | PRE-TARGETING STRATEGIES FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-10-10 | — | — | US | disclosed |
| US-20240299599-A1 | DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION (US) | 2024-09-12 | — | — | US | disclosed |
| US-12029798-B2 | Pre-targeting strategies for molecular imaging and/or radioimmunotherapy | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-07-09 | — | — | US | disclosed |
| US-11931423-B2 | Glucose oxidase-nanoparticle bioconjugates for cancer treatment | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-03-19 | — | — | US | disclosed |
| US-11857648-B2 | Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy | University of Pittsburgh—of the Commonwealth System of Higher Education (US) | 2024-01-02 | — | — | US | disclosed |
| WO-2023052127-A1 | PVC MIXTURE | LEONI KABEL GMBH (DE) | 2023-04-06 | — | — | WO | disclosed |
| EP-2997076-B1 | SUPRAMOLECULAR BIODEGRADABLE POLYMER | SUPRAPOLIX BV (NL) | 2022-03-16 | — | — | EP | disclosed |
| US-20040220356-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220377-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220378-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220373-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220376-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220357-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220371-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| US-20040220375-A1 | Compositions for golf equipment | JPMORGAN CHASE BANK, N.A., AS SUCCESSOR ADMINISTRATIVE AGENT | 2004-11-04 | — | — | US | disclosed |
| WO-2004051221-A2 | MEASUREMENT OF TOTAL REACTIVE ISOCYANATE GROUPS IN SAMPLES USING BIFUNCTIONAL NUCLEOPHILES SUCH AS 1,8-DIAMINONAPHTHALENE (DAN) | THE GOVERNMENT OF THE UNITED STATES OF AMERICA (US) | 2004-06-17 | — | — | WO | disclosed |
| US-20040100600-A1 | Retarders, circular polarizer and processes for preparing them | FUJI PHOTO FILM CO., LTD. | 2004-05-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240299599-A1 | DIMERIZATION STRATEGIES AND COMPOUNDS FOR MOLECULAR IMAGING AND/OR RADIOIMMUNOTHERAPY | PAICS, CD47, BID | CA1 169/4885CYP2D6 4476/4885CA9 282/4885 |
| US-11931423-B2 | Glucose oxidase-nanoparticle bioconjugates for cancer treatment | G6PD, PPOX, DUOX1 | CA1 293/4885CYP2D6 660/4885CA9 69/4885 |
| US-11857648-B2 | Dimerization strategies and compounds for molecular imaging and/or radioimmunotherapy | PAICS, CD47, BID | CA1 169/4885CYP2D6 4476/4885CA9 282/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.